Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3 + 4 Favorable Intermediate-risk Prostate Cancer

54

Citations

27

References

2017

Year

David D. Yang, Brandon A. Mahal, Vinayak Muralidhar, Michelle D. Nezolosky, M. Vastola, Shelby A. Labe, Ninjin Boldbaatar, Martin T. King, Neil E. Martin, Peter F. Orio,

European Urology Focus

UrologyGenitourinary CancerMedicinePathologyProstatic DiseaseOncologyGleason 3

References

	Year	Citations

Page 1